Naltrekson Aop (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrekson Aop, is an opioid antagonist presented as an oral tablet for oral use. It treats alcohol dependence and opioid dependence (maintenance/relapse prevention) in adult patients.

GNH USA supplies Naltrekson Aop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone is used in the management of disorders related to alcohol and opioid use, acting on the central nervous system to reduce reinforcement.

Alcohol dependence: helps reduce cravings and supports abstinence. Opioid dependence (maintenance): blocks opioid receptors to prevent relapse. Opioid use disorder (relapse prevention): diminishes the rewarding effects of opioids, aiding long‑term recovery.

Naltrexone may cause a range of adverse reactions, from mild to severe. Patients should be monitored for any new symptoms.

Common Side Effects: - Nausea - Headache - Dizziness - Fatigue - Insomnia - Abdominal pain

Serious or Rare Side Effects: - Hepatotoxicity or elevated liver enzymes - Severe allergic reactions, including anaphylaxis - Depression or suicidal thoughts - Hepatic failure - Severe rash or skin reactions - Acute withdrawal syndrome if opioids are present

Before initiating therapy, clinicians should evaluate patient history and monitor for potential risks.

Assess liver function: perform baseline hepatic tests and monitor periodically. Monitor mental health: watch for depression, suicidal ideation, or mood changes. Avoid use in acute opioid intoxication: may precipitate withdrawal. Do not discontinue abruptly: taper under medical supervision to avoid withdrawal. Use caution in renal impairment: adjust dosing if necessary. Store at ambient temperature: keep in the original pack, protect from moisture.

Naltrexone can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Opioid analgesics: can precipitate acute withdrawal. - Disulfiram: may increase risk of hepatotoxicity. - Benzodiazepines: combined use can enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Alcohol: may increase sedation and liver strain. - Antidepressants: potential for increased side effects. - CYP2D6 inhibitors: may alter naltrexone metabolism, requiring dose adjustment.